It's on the CSL website:
https://www.csl.com/news/2020/20200706-csl-behring-begins-trial-to-evaluate-monoclonal-antibody-for-respiratory-distress
In the CSL scheme of things it's probably not considered significant enough for an ASX announcement, it's just another one of who knows how many things going on at CSL.
Of note: "CSL Behring now evaluating 5 approaches to preventing and treating COVID-19. "
Coronavirus, page-106
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$295.21 |
Change
0.050(0.02%) |
Mkt cap ! $142.6B | |||
| Open | High | Low | Value | Volume |
| $296.30 | $298.20 | $295.00 | $229.6M | 780.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 248 | $295.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $295.21 | 42 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| CSL (ASX) Chart |